The data presented in our publication are identical to the results of other researchers who also showed deregulation of CTLA-4 in the course of CLL (increased expression on selected populations of immune system cells) [46,47,48,49]. This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.